Drug wholesaler AmerisourceBergen is dropping after Walgreens has reportedly ended acquisition talks

  • Pharmacy giant Walgreens has ended its talks with drug wholesaler AmerisourceBergen about a potential acquisition, CNBC reported Tuesday.
  • AmerisourceBergen’s stock dropped by as much as 6% on the news.
  • AmerisourceBergen is one of three drug distributors that distribute about 90% of the US’s medications to pharmacies and hospitals.
  • On February 12, The Wall Street Journal reported Walgreens, which already owns about 26% of the drug distributor, had reportedly approached the company about a potential takeover.
  • AmerisourceBergen shares are up about 4% this year, including Tuesday’s losses.

Screen Shot 2018 02 27 at 1.14.53 PMMarkets Insider

NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at research.businessinsider.com.au.